Castle Biosciences - Stock Price History | CSTL

Historical daily share price chart and data for Castle Biosciences since 2021 adjusted for splits. The latest closing stock price for Castle Biosciences as of October 22, 2021 is 62.73.
  • The all-time high Castle Biosciences stock closing price was 97.33 on February 09, 2021.
  • The Castle Biosciences 52-week high stock price is 107.69, which is 71.7% above the current share price.
  • The Castle Biosciences 52-week low stock price is 43.37, which is 30.9% below the current share price.
  • The average Castle Biosciences stock price for the last 52 weeks is 67.13.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Castle Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 40.8689 33.8200 73.0500 23.0800 67.1500 95.37%
2019 23.4854 21.4000 35.0400 15.7400 34.3700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.579B $0.063B
Castle Biosciences Inc. is a commercial-stage dermatological cancer company. It is focused on providing physicians and patients, clinically actionable genomic information. Castle Biosciences Inc. is based in Texas, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76